Long-acting lenacapavir is a breakthrough for preventing HIV infection, but HIV vaccine research must continue

Related Experiment Video

Updated: Jun 12, 2025

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

5.8K

Caijun Sun1, Linghua Li2, Pingchao Li3

  • 1School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, 518107, China.

Frontiers of Medicine
|June 11, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.3K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

454

Related Experiment Videos

Last Updated: Jun 12, 2025

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

5.8K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.3K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

454

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K

Articles linked to this work by shared authors, journal, and citation graph.

Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity.

Acta pharmaceutica Sinica. B·2026

Characterizing recent HIV infection by high-fidelity multiplexed Primer ID-based next-generation sequencing among newly diagnosed individuals in Zhuhai, China: a cross-sectional study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study.

Viruses·2026

Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice.

Vaccine·2026

Trends in HIV/AIDS Knowledge and Self-Testing Preferences Among College Students: A Five-Year Repeated Cross-Sectional Survey in Shenzhen, China.

AIDS research and human retroviruses·2026

IL-19 Modulates Antiviral Immunity and Inflammation via IL-20RB/STAT3/TRIM22 Signaling Pathway.

Journal of medical virology·2026

Immune cells in diabetic wound repair: the key to better wound management.

Frontiers of medicine·2025

LMWH prophylaxis in pregnancy outcomes of women with suspected protein S deficiency: a retrospective case-control study.

Frontiers of medicine·2025

Roles of different methylation modifications in cardiovascular disease.

Frontiers of medicine·2025

Prognostic utility of baseline ASCL1/INSM1 expression and neutrophil-lymphocyte ratio in unresectable SCLC treated with first-line chemoimmunotherapy with or without radiotherapy.

Frontiers of medicine·2025

Risk prediction and therapeutic targets for incident pulmonary hypertension: a large-scale proteomic profiling and Mendelian randomization study.

Frontiers of medicine·2025

ASPH interacts with RUVBL2 to promote tumor metastasis in lung adenocarcinoma via MAPK and Notch signaling pathways.

Frontiers of medicine·2025
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us